Idiosyncratic drug hepatotoxicity
The DOI matches its Crossref record; 154 of the 155 references it cites were found in a registry or an index.
Abstract
The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the most frequent cause of post-marketing warnings and withdrawals. This review examines the clinical signatures of this problem, signals predictive of its occurrence (particularly of more frequent, reversible, low-grade injury) and the role of monitoring in prevention by examining several recent examples (for example, troglitazone). In addition, the failure of preclinical toxicology to predict idiosyncratic reactions, and what can be done to improve this problem, is discussed. Finally, our current understanding of the pathophysiology of experimental drug hepatotoxicity is examined, focusing on acetaminophen, particularly with respect to the role of the innate immune system and control of cell-death pathways, which might provide targets for exploration and identification of risk factors and mechanisms in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current drug development process suffers from a high failure rate during clinical trials, which is partly due to inadequacy of animal models to accurately predict the toxic side-effects of drugs in humans [1,2].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [2]
In the citing paper
“Drug-induced liver injury (DILI) is a common adverse drug reaction (ADR), and it can lead to liver failure and even death.[1][2][3]”
From Incidence and Etiology of Drug-Induced Liver Injury in Mainland China (2019) · cites this paper as [1]
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
Schwartz, G. G. (2001) · JAMA · doi:10.1001/jama.285.13.1711 · Cited by 2,499
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. II. ROLE OF COVALENT BINDING IN VIVO
Jollow, D. J., Mitchell, J. R., Potter, W. Z., Davis, D. C., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29664-1 · Cited by 1,204
Acetaminophen-induced Hepatic Necrosis
Jollow, D. J., Thorgeirsson, S. S., Potter, W. Z., Hashimoto, M., & Mitchell, J. R. (1974) · Pharmacology · doi:10.1159/000136547 · Cited by 1,092
ANDRADE, R., LUCENA, M., FERNANDEZ, M., PELAEZ, G., PACHKORIA, K., GARCIARUIZ, E., GARCIAMUNOZ, B., GONZALEZGRANDE, R., PIZARRO, A., & DURAN, J. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.006 · Cited by 856
Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease
Watkins, P. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370044030 · Cited by 829
Research works printed but not linked: 3
- Nelson, S. D. & Bruschi, S. A. in Drug-Induced Liver Disease (eds Kaplowitz, N. & DeLeve, L.) 287–325 (Marcel Dekker, New York, 2003).
- Chien, J. Y., Thummel, K. E. & Slattery, J. T. Pharmakinetic consequence of induction of CYP2E1 by ligand stabilization. Drug Metab. Dispos. 25, 1165–1175 (1997).
- Liu, Z. -X. & Kaplowitz, N. in Clinics in Liver Disease 6, 467–486 (Elsevier, 2002).
Cited by
Items 901–999 of 999
Grillo, M. P. (2008) · doi:10.1002/9780470439265.ch22 · Cited by 1
Wojcinski, Z. W., & Uetrecht, J. (2012) · Wiley eBooks · doi:10.1002/9780470921920.edm087 · Cited by 1
Drug Metabolism in Drug Safety Evaluation
Baillie, T. A. (2012) · Encyclopedia of Drug Metabolism and Interactions · doi:10.1002/9780470921920.edm054 · Cited by 1
Leiro‐Fernández, V., Fernández‐Villar, A., Vázquez-Gallardo, R., & Valverde, D. (2009) · Hepatology · doi:10.1002/hep.22910 · Cited by 1
Translational Mechanistic Biomarkers and Models for Predicting Drug‐Induced Liver Injury
Antoine, D. J. (2016) · Wiley eBooks · doi:10.1002/9781119053248.ch27 · Cited by 1
Liver Disease in Renal Transplant Recipients
Said, A., Safdar, N., Wells, J. T., & Lucey, M. R. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3343-1.50034-7 · Cited by 1
Acute and Chronic Liver Diseases Induced by Drugs or Xenobiotics
van Pelt, F. N. A. M., Carey, M. A., & Carey, J. B. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-518-3_30 · Cited by 1
Slizgi, J. R. (2017) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/v0kz-1a18 · Cited by 1
Chemical Mechanisms in Toxicology
Grillo, M. P. (2008) · Wiley eBooks · doi:10.1002/9780470439265.ch23 · Cited by 1
Zoubek, M. E. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210929mz · Cited by 1
Grillo, M. P. (2010) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse121 · Cited by 1
NONCLINICAL MANIFESTATIONS, MECHANISMS, AND END POINTS OF DRUG TOXICITY
Gad, S. C. (2016) · doi:10.1002/9781119097440.ch6 · Cited by 1
Grillo, M. P. (2022) · doi:10.1002/9781119851042.ch20 · Cited by 1
Liver Injury Associated with Ocrelizumab Use: A Case ReportPreprint
Harata, M., Rustam, L. B., & Gunderson, A. (2023) · Preprints.org · doi:10.20944/preprints202304.0705.v1
Dhongadi, M. R., Pattanashetti, L. A., & Patil, V. S. (2023) · Research Square · doi:10.21203/rs.3.rs-3237131/v1 · Cited by 1
Odin, J. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-26711-6.00027-5 · Cited by 1
Lee, C., Tasnim, F., Huang, X., Sethi, R., Song, Y., Kozaki, T., Schepper, S. D., Ang, N., Low, I., Hwang, Y. Y., et al. (2025) · eLife · doi:10.7554/elife.108938.1 · Cited by 1
Lee, C., Tasnim, F., Huang, X., Sethi, R., Song, Y., Kozaki, T., Schepper, S. D., Ang, N., Low, I., Hwang, Y. Y., et al. (2025) · eLife · doi:10.7554/elife.108938 · Cited by 3
Hasan, M. A. (2007) · DSpace@MIT (Massachusetts Institute of Technology)
Cell‐free microRNAs as Biomarkers in Human Diseases
Yang, X., Mattes, W. B., Shi, Q., Weng, Z., & Salminen, W. F. (2013) · Wiley eBooks · doi:10.1002/9781118695999.ch22
Drug Metabolism Research as Integral Part of Drug Discovery and Development Processes
Humphreys, W. G. (2011) · Wiley eBooks · doi:10.1002/9780470929278.ch7
Mechanistic Safety Biomarkers for Drug‐Induced Liver Injury
Antoine, D. J. (2015) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673643.ch06
Drug Metabolism and Pharmacokinetics in Toxicology
Curry, S. H., & PhD, R. W. (2010) · Wiley eBooks · doi:10.1002/9780470665190.ch18
Focus on the Fundamentals: Toward Better Therapeutic Index Prediction
Xu, J. J., & Yu, L. J. (2008) · Wiley eBooks · doi:10.1002/9780470431818.ch1
Damsten, M. C. (2009) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Predicting drug-induced liver injury: safer patients or safer drugs?
Xu, J. J. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511779053.006
Metabolic Activation and Associated Drug Toxicity
Baillie, T. A. (2014) · Handbook of Metabolic Pathways of Xenobiotics · doi:10.1002/9781118541203.xen0014
Evans, D. C. (2012) · Wiley eBooks · doi:10.1002/9780470921920.edm075 · Cited by 1
Chemical Mechanisms in Toxicology
Grillo, M. P. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse122
Ali, G. Y. (2012) · Figshare
Gene expression profiling in primary rat hepatocytes for the prediction of hepatotoxicity
Lauer, B. (2012) · Technischen Universität Darmstadt · doi:10.26083/tuprints-00003064
Jaeschke, H. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_42
Fulminant Hepatic Failure: Diagnosis and Management
Marzio, D. H., & Sass, D. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-05543-5_16-1
Rocha, S. C. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2011.tde-16082011-160411
Hepatic safety and possible hepatotoxic action of the metabolites of some pharmaceutical drugs
Georgieva, S. F. (2013) · Scripta Scientifica Medica · doi:10.14748/ssm.v45i2.321
Infrared spectroscopic studies to understand the effect of drugs at molecular level
Singh, B., Gautam, R., Chandrasekar, B., Rakshit, S., N., V. K. B., Boopathy, S., Nandi, D., Somasundaram, K., & Umapathy, S. (2012) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.922402
Dragović, S. (2013) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) · Cited by 1
Abbas, R. F., Ibrahim, K. M., & Alzubaidi, S. F. (2014) · Journal of University of Babylon for Pure and Applied Sciences
Harrill, A. H. (2009) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/xz0h-f855
Role of Inflammation in Metabolism and Hepatotoxicity of Prototypical Drugs
Gandhi, A. S. (2012)
Tsaioun, K. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782620136-00110
Wing, K. (2016) · LSHTM Research Online (London School of Hygiene and Tropical Medicine) · doi:10.17037/pubs.02545199
Ishikawa, T., Fukami, T., Nagakura, M., & Hirano, H. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622376-00333 · Cited by 1
drug-induced liver injury Diagnosis, management and prevention of
Verma, S., & Kaplowitz, N. (2009)
Self-citationWahlin, M. D. (2014) · ResearchWorks at the University of Washington (University of Washington)
Review of Pathophysiological Aspects and Risk Factors for Liver Dysfunction
Omar, H. E.-D. M. (2016) · Archives of Clinical Gastroenterology · doi:10.17352/2455-2283.000025
Aswani, T., Manalu, W., Suprayogi, A., & Rahminiwati, M. (2016)
Engineered Liver Platforms for Different Phases of Drug
Khetani, S. R. (2017)
Risperidon Kullanımına Bağlı Ortaya Çıkan Akut Toksik Hepatit: Olgu Sunumu
Gündüz, N., & Turgut, C. (2018) · Kocaeli Üniversitesi Sağlık Bilimleri Dergisi · doi:10.30934/kusbed.366173
de Campos, A. M. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.75.2018.tde-28082018-163810
Hepatotoxicity of New Oral Anticoagulants
Kasimova, A. R., Philippova, A. V., & Колбин, А. С. (2018) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2018-14-4-621-628
Cui, J., Wang, H., Shi, Q., Li, J., Zheng, Z., Sun, T., Huang, Q., & Fukuda, T. (2018) · International Conference on Manipulation, Automation and Robotics at Small Scales (MARSS) · doi:10.1109/marss.2018.8481232
Xu, J. J., & Hoffmaster, K. A. (2010) · Wiley eBooks · doi:10.1002/9780470915110.ch8
Huang, H.-C., Lee, S., Lin, C., Lee, M., & Dong, C. (2019) · doi:10.1117/12.2507347
Nanopartículas lipídicas sólidas encapsulando curcuminoides (NLS-CT): estudos in vitro e in vivo
Zamarioli, C. M. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2019.tde-02102018-155442
Effect of liver diseases on hormonal and biochemical parameters in Wistar albino rat
Mohamed, A. H., Kamal, H. H., Ahmed, W. M. S., & Saeed, H. E. (2018) · Journal of Veterinary Medical Research · doi:10.21608/jvmr.2018.43299
Kukla, D. A., Stoppel, W. L., Kaplan, D. L., & Khetani, S. R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.30.927814
AL-Awwadi, N. A. J. (2016) · Journal of Pharmaceutical and Pharmacological Sciences · doi:10.29011/2574-7711.100007
de Montellano, P. R. O. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00409-7
Cichocki, J. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813724-6.00057-8
Díaz-García, J. D., Pozos-López, J. T., Cruz-Trujillo, A., Leal-Ahumada, C. A., Fuentes-Venegas, A., & Córdova‐Gallardo, J. (2020) · Hospital medicine and clinical management · doi:10.24875/hmcm.19000222
Ranitidine Induced Hepatotoxicity: A Review
Banerjee, A. B., Gupta, M., Singh, T. G., Arora, S., & Bedi, O. (2020) · Journal of Pharmaceutical Technology Research and Management · doi:10.15415/jptrm.2020.81006
Zeiss, R., & Gahr, M. (2021) · Nervenheilkunde · doi:10.1055/a-1300-7298
Use of liver cells to discover novel peptides for anti-Zika strategies
Khazali, A. S., & Yusof, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820267-8.00042-x
Review Article Drug Impairment and Liver Disease
Atrees, S. S. (2021) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2021.184505
Microfluidic systems for drug discovery, pharmaceutical analysis, and diagnostic applications
Ding, D., Park, S., Kochhar, J. S., Chan, S. Y., Ong, P. S., Lee, W. G., & Kang, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819971-8.00019-6 · Cited by 1
Nortriptyline Induces Sterile Inflammation by Directly Targeting NLRP3 Inflammasome ActivationPreprint
Mu, W., Xu, G., Wang, Z., Li, Q., Sun, S., Qin, Q., Li, Z., Shi, W., Dai, W., Zhan, X., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3904659
Drug-Induced Liver Injury in Children: A Structured Approach to Diagnosis and Management
Lopez, M. J., & Bilhartz, J. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9005-0_19
Deneysel Modellerde İlaca Bağlı Hepatotoksisite
Samancı, T. Ç. (2021) · Tıpta Yenilikçi Yaklaşımlar Dergisi · doi:10.29329/jiam.2021.411.3
Fickert, P., & Trauner, M. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch24c
Diagnostics and Outcome Predictorso Drug Induced Liver Injury: A Single Center Prospective Study
Alhaddad, O., ElSharkawy, A. S., Hendy, O. M., Elsabaawy, M., Mazaly, M. A., & Sabry, A. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.215204
Current awareness: Pharmacoepidemiology and drug safety
(2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1034
(2006) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/01.all.0000235907.33418.68
(2010) · Wiley eBooks · doi:10.1002/9781444325201.furread
Arzneimittelinduzierte Leberschäden
zu Siederdissen, C. H., & Cornberg, M. (2014) · Springer eBooks · doi:10.1007/978-3-642-54676-1_151-1
Arzneimittelinduzierte Leberschäden
zu Siederdissen, C. H., & Cornberg, M. (2016) · Springer eBooks · doi:10.1007/978-3-642-41620-0_18
Trost, D. C. (2014) · Wiley eBooks · doi:10.1002/9781118763070.ch9 · Cited by 1
Jilma, B., & Müller, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-27347-1_19
Lee, W. M. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch97
Teranishi, M., & Manabe, S. (2008) · Folia Pharmacologica Japonica · doi:10.1254/fpj.132.347
Arzneimittelinduzierte Leberschäden
zu Siederdissen, C. H., & Cornberg, M. (2016) · Springer eBooks · doi:10.1007/978-3-642-41620-0_151
(2010) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse134
Applications of liver organoids
Li, C., ZHANG, Z., ShuangShu, D. O. N. G., & Hui, L. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0098
de Montellano, P. R. O. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95620-4
Gad, S. C. (2010) · doi:10.1002/9780470464151.ch8
Ramachandran, A., & Jaeschke, H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65717-3
Discovery of Bakuchiol as Aim2 Inflammasome Activator and Cause HepatotoxicityPreprint
Liu, T., Guang, X., Li, Y., Wei, S., Ren, L., Zhie, F., Liang, L., Wang, Y., Gao, Y., Xiaoyan, Z., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4145409
Chemical Mechanisms in Toxicology
Grillo, M. P. (2022) · Wiley eBooks · doi:10.1002/9781119851042.ch21
da Trindade, H. I. (2023) · Seven Editora eBooks · doi:10.56238/sevenediefatiamodelodenoqt-004
da Trindade, H. I. (2023) · Seven Editora eBooks · doi:10.56238/sevenediefatiamodelodenoqt-001
Metadata
- Authors
- Kaplowitz, N.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Kaplowitz, Neil
- ORCID
- Kaplowitz, Neil
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-06
- Volume
- 4
- Issue
- 6
- Pages
- 489-499
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2017783406
- Cited by
- 1,054
- References
- 155
- Citations by year
- 2026: 29 · 2025: 35 · 2024: 35 · 2023: 44 · 2022: 31 · 2021: 49 · 2020: 45 · 2019: 48 · 2018: 54 · 2017: 66 · 2016: 72 · 2015: 55 · 2014: 64 · 2013: 57 · 2012: 52
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- drug-induced liver injury, troglitazone, preclinical toxicology, hepatotoxicity prediction, pharmacovigilance, acetaminophen hepatotoxicity, innate immune system, cell death pathways, drug withdrawal, post-marketing surveillance
- MeSH terms
- Animals, Pharmaceutical Preparations, Humans, Liver, Liver Diseases, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.